Health-Related Quality of Life in KEYNOTE-010: a Phase 2/3 Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, PD-L1–Expressing NSCLC User montaukwhaler, in the non small cell lung cancer subreddit, 05 Feb 2019